AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
FDA Orphan Drug Designation for PTX252 in AML Treatment
Exploring the FDA's recognition of PTX252 as an orphan drug for acute myeloid leukemia, focusing on its potential to enhance chemotherapy sensitivity in rare blood cancer cases.